{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:14:47Z","timestamp":1792671287764,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1141587"],"award-info":[{"award-number":["1141587"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neovascular AMD (nAMD) leads to vision loss and is a leading cause of visual impairment in the industrialised world. Current treatments that target blood vessel growth have not been able to treat subretinal fibrosis and nAMD patients continue to lose vision. The molecular mechanisms involved in the development of fibrotic lesions in nAMD are not well understood. The aim of this study was to further understand subretinal fibrosis in the laser photocoagulation model of choroidal neovascularization (CNV) by studying the whole transcriptome of the RPE\/choroid following CNV and the application of an anti-fibrotic following CNV. Seven days after laser induced CNV, RPE and choroid tissue was separated and underwent RNAseq. Differential expression analysis and pathway analysis revealed an over representation of immune signalling and fibrotic associated pathways in CNV compared to control RPE\/choroid tissue. Comparisons between the mouse CNV model to human CNV revealed an overlap in upregulated expression for immune genes (Ccl2, Ccl8 and Cxcl9) and extracellular matrix remodeling genes (Comp, Lrcc15, Fndc1 and Thbs2). Comparisons between the CNV model and other fibrosis models showed an overlap of over 60% of genes upregulated in either lung or kidney mouse models of fibrosis. Treatment of CNV using a novel cinnamoyl anthranilate anti-fibrotic (OCX063) in the laser induced CNV model was selected as this class of drugs have previously been shown to target fibrosis. CNV lesion leakage and fibrosis was found to be reduced using OCX063 and gene expression of genes within the TGF-beta signalling pathway. Our findings show the presence of fibrosis gene expression pathways present in the laser induced CNV mouse model and that anti-fibrotic treatments offer the potential to reduce subretinal fibrosis in AMD.<\/jats:p>","DOI":"10.1038\/s41598-022-04845-4","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T06:03:22Z","timestamp":1642399402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Transcriptomic analysis of choroidal neovascularization reveals dysregulation of immune and fibrosis pathways that are attenuated by a novel anti-fibrotic treatment"],"prefix":"10.1038","volume":"12","author":[{"given":"Alice","family":"Brandli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fay L.","family":"Khong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy C. K.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"4845_CR1","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1056\/NEJMra0801537","volume":"358","author":"RD Jager","year":"2008","unstructured":"Jager, R. D., Mieler, W. F. & Miller, J. W. Age-related macular degeneration. N. Engl. J. Med. 358, 2606\u20132617. https:\/\/doi.org\/10.1056\/NEJMra0801537 (2008).","journal-title":"N. Engl. J. Med."},{"key":"4845_CR2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld, P. J. et al. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1419\u20131431. https:\/\/doi.org\/10.1056\/NEJMoa054481 (2006).","journal-title":"N. Engl. J. Med."},{"key":"4845_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005139.pub4","volume":"3","author":"SD Solomon","year":"2019","unstructured":"Solomon, S. D., Lindsley, K., Vedula, S. S., Krzystolik, M. G. & Hawkins, B. S. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst. Rev. 3, CD005139. https:\/\/doi.org\/10.1002\/14651858.CD005139.pub4 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"4845_CR4","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ophtha.2013.10.019","volume":"121","author":"E Daniel","year":"2014","unstructured":"Daniel, E. et al. Risk of scar in the comparison of age-related macular degeneration treatments trials. Ophthalmology 121, 656\u2013666. https:\/\/doi.org\/10.1016\/j.ophtha.2013.10.019 (2014).","journal-title":"Ophthalmology"},{"key":"4845_CR5","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.ophtha.2018.01.004","volume":"125","author":"E Daniel","year":"2018","unstructured":"Daniel, E. et al. Development and course of scars in the comparison of age-related macular degeneration treatments trials. Ophthalmology 125, 1037\u20131046. https:\/\/doi.org\/10.1016\/j.ophtha.2018.01.004 (2018).","journal-title":"Ophthalmology"},{"key":"4845_CR6","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","volume":"120","author":"S Rofagha","year":"2013","unstructured":"Rofagha, S., Bhisitkul, R. B., Boyer, D. S., Sadda, S. R. & Zhang, K. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: A multicenter cohort study (SEVEN-UP). Ophthalmology 120, 2292\u20132299. https:\/\/doi.org\/10.1016\/j.ophtha.2013.03.046 (2013).","journal-title":"Ophthalmology"},{"key":"4845_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S0002-9394(14)71859-8","volume":"114","author":"HE Grossniklaus","year":"1992","unstructured":"Grossniklaus, H. E. et al. Immunohistochemical and histochemical properties of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am. J. Ophthalmol. 114, 464\u2013472. https:\/\/doi.org\/10.1016\/S0002-9394(14)71859-8 (1992).","journal-title":"Am. J. Ophthalmol."},{"key":"4845_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ophtha.2018.08.035","volume":"126","author":"GJ Jaffe","year":"2019","unstructured":"Jaffe, G. J. et al. Macular morphology and visual acuity in year five of the comparison of age-related macular degeneration treatments trials. Ophthalmology 126, 252\u2013260. https:\/\/doi.org\/10.1016\/j.ophtha.2018.08.035 (2019).","journal-title":"Ophthalmology"},{"key":"4845_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.oret.2017.08.019","volume":"2","author":"G Casalino","year":"2018","unstructured":"Casalino, G., Stevenson, M. R., Bandello, F. & Chakravarthy, U. Tomographic biomarkers predicting progression to fibrosis in treated neovascular age-related macular degeneration: A multimodal imaging study. Ophthalmology Retina 2, 451\u2013461. https:\/\/doi.org\/10.1016\/j.oret.2017.08.019 (2018).","journal-title":"Ophthalmology Retina"},{"key":"4845_CR10","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1097\/iae.0000000000001748","volume":"38","author":"R Pokroy","year":"2018","unstructured":"Pokroy, R. et al. Prognostic value of subretinal hyperreflective material in neovascular age-related macular degeneration treated with bevacizumab. Retina 38, 1485\u20131491. https:\/\/doi.org\/10.1097\/iae.0000000000001748 (2018).","journal-title":"Retina"},{"key":"4845_CR11","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.ajpath.2020.04.004","volume":"190","author":"A Schlecht","year":"2020","unstructured":"Schlecht, A. et al. Transcriptomic characterization of human choroidal neovascular membranes identifies calprotectin as a novel biomarker for patients with age-related macular degeneration. Am. J. Pathol. 190, 1632\u20131642. https:\/\/doi.org\/10.1016\/j.ajpath.2020.04.004 (2020).","journal-title":"Am. J. Pathol."},{"key":"4845_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ajo.2005.07.025","volume":"141","author":"RF Spaide","year":"2006","unstructured":"Spaide, R. F. Rationale for combination therapies for choroidal neovascularization. Am. J. Ophthalmol. 141, 149\u2013156. https:\/\/doi.org\/10.1016\/j.ajo.2005.07.025 (2006).","journal-title":"Am. J. Ophthalmol."},{"key":"4845_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12974-020-02033-7","volume":"17","author":"K Little","year":"2020","unstructured":"Little, K. et al. Macrophage to myofibroblast transition contributes to subretinal fibrosis secondary to neovascular age-related macular degeneration. J. Neuroinflamm. 17, 355. https:\/\/doi.org\/10.1186\/s12974-020-02033-7 (2020).","journal-title":"J. Neuroinflamm."},{"key":"4845_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/gm315","volume":"4","author":"AM Newman","year":"2012","unstructured":"Newman, A. M. et al. Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med. 4, 16. https:\/\/doi.org\/10.1186\/gm315 (2012).","journal-title":"Genome Med."},{"key":"4845_CR15","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.18632\/aging.100711","volume":"6","author":"E Makarev","year":"2014","unstructured":"Makarev, E. et al. Pathway activation profiling reveals new insights into age-related macular degeneration and provides avenues for therapeutic interventions. Aging 6, 1064\u20131075. https:\/\/doi.org\/10.18632\/aging.100711 (2014).","journal-title":"Aging"},{"key":"4845_CR16","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.ajpath.2016.02.018","volume":"186","author":"K Strittmatter","year":"2016","unstructured":"Strittmatter, K., Pomeroy, H. & Marneros, A. G. Targeting platelet-derived growth factor receptor \u03b2(+) scaffold formation inhibits choroidal neovascularization. Am. J. Pathol. 186, 1890\u20131899. https:\/\/doi.org\/10.1016\/j.ajpath.2016.02.018 (2016).","journal-title":"Am. J. Pathol."},{"key":"4845_CR17","doi-asserted-by":"publisher","first-page":"12216","DOI":"10.1073\/pnas.1004143107","volume":"107","author":"X Hou","year":"2010","unstructured":"Hou, X. et al. PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets. Proc. Natl. Acad. Sci. U.S.A. 107, 12216\u201312221. https:\/\/doi.org\/10.1073\/pnas.1004143107 (2010).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"4845_CR18","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.2353\/ajpath.2006.050588","volume":"168","author":"N Jo","year":"2006","unstructured":"Jo, N. et al. Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am. J. Pathol. 168, 2036\u20132053. https:\/\/doi.org\/10.2353\/ajpath.2006.050588 (2006).","journal-title":"Am. J. Pathol."},{"key":"4845_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ophtha.2016.10.010","volume":"124","author":"GJ Jaffe","year":"2017","unstructured":"Jaffe, G. J. et al. Dual antagonism of PDGF and VEGF in neovascular age-related macular degeneration. Ophthalmology 124, 224\u2013234. https:\/\/doi.org\/10.1016\/j.ophtha.2016.10.010 (2017).","journal-title":"Ophthalmology"},{"key":"4845_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0002-9394(14)72158-0","volume":"120","author":"VM Reddy","year":"1995","unstructured":"Reddy, V. M., Zamora, R. L. & Kaplan, H. J. Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome. Am. J. Ophthalmol. 120, 291\u2013301. https:\/\/doi.org\/10.1016\/S0002-9394(14)72158-0 (1995).","journal-title":"Am. J. Ophthalmol."},{"key":"4845_CR21","first-page":"3178","volume":"35","author":"R Amin","year":"1994","unstructured":"Amin, R., Puklin, J. E. & Frank, R. N. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 35, 3178\u20133188 (1994).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"4845_CR22","first-page":"1222","volume":"17","author":"M Hirasawa","year":"2011","unstructured":"Hirasawa, M. et al. Transcriptional factors associated with epithelial\u2013mesenchymal transition in choroidal neovascularization. Mol. Vis. 17, 1222\u20131230 (2011).","journal-title":"Mol. Vis."},{"key":"4845_CR23","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/archopht.122.7.1013","volume":"122","author":"SW Cousins","year":"2004","unstructured":"Cousins, S. W., Espinosa-Heidmann, D. G. & Csaky, K. G. Monocyte activation in patients with age-related macular degeneration: A biomarker of risk for choroidal neovascularization?. Arch. Ophthalmol. 122, 1013\u20131018. https:\/\/doi.org\/10.1001\/archopht.122.7.1013 (2004).","journal-title":"Arch. Ophthalmol."},{"key":"4845_CR24","doi-asserted-by":"publisher","first-page":"9672","DOI":"10.1038\/s41598-017-10124-4","volume":"7","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. TGF-\u03b2 participates choroid neovascularization through Smad2\/3-VEGF\/TNF-\u03b1 signaling in mice with laser-induced wet age-related macular degeneration. Sci. Rep. 7, 9672\u20139672. https:\/\/doi.org\/10.1038\/s41598-017-10124-4 (2017).","journal-title":"Sci. Rep."},{"key":"4845_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065434","volume":"8","author":"J Zarranz-Ventura","year":"2013","unstructured":"Zarranz-Ventura, J. et al. Transforming growth factor-beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptides. PLoS\u00a0One 8, e65434. https:\/\/doi.org\/10.1371\/journal.pone.0065434 (2013).","journal-title":"PLoS\u00a0One"},{"key":"4845_CR26","first-page":"459","volume":"40","author":"Y Takehana","year":"1999","unstructured":"Takehana, Y. et al. Suppression of laser-induced choroidal neovascularization by oral tranilast in the rat. Investig. Ophthalmol. Vis. Sci. 40, 459\u2013466 (1999).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"4845_CR27","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.42049","volume":"8","author":"W Ma","year":"2019","unstructured":"Ma, W. et al. Absence of TGF\u03b2 signaling in retinal microglia induces retinal degeneration and exacerbates choroidal neovascularization. Elife 8, e42049. https:\/\/doi.org\/10.7554\/eLife.42049 (2019).","journal-title":"Elife"},{"key":"4845_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.phrs.2014.10.009","volume":"91","author":"S Darakhshan","year":"2015","unstructured":"Darakhshan, S. & Pour, A. B. Tranilast: A review of its therapeutic applications. Pharmacol. Res. 91, 15\u201328. https:\/\/doi.org\/10.1016\/j.phrs.2014.10.009 (2015).","journal-title":"Pharmacol. Res."},{"key":"4845_CR29","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/sj.bjp.0701493","volume":"122","author":"M Isaji","year":"1997","unstructured":"Isaji, M., Miyata, H., Ajisawa, Y., Takehana, Y. & Yoshimura, N. Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo. Br. J. Pharmacol. 122, 1061\u20131066. https:\/\/doi.org\/10.1038\/sj.bjp.0701493 (1997).","journal-title":"Br. J. Pharmacol."},{"key":"4845_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/02844319709085482","volume":"31","author":"S Shigeki","year":"1997","unstructured":"Shigeki, S., Murakami, T., Yata, N. & Ikuta, Y. Treatment of keloid and hypertrophic scars by iontophoretic transdermal delivery of tranilast. Scand. J. Plast. Reconstr. Surg. Hand Surg. 31, 151\u2013158. https:\/\/doi.org\/10.3109\/02844319709085482 (1997).","journal-title":"Scand. J. Plast. Reconstr. Surg. Hand Surg."},{"key":"4845_CR31","doi-asserted-by":"publisher","first-page":"7003","DOI":"10.1016\/j.bmcl.2009.09.120","volume":"19","author":"SC Zammit","year":"2009","unstructured":"Zammit, S. C. et al. Evaluation and optimization of antifibrotic activity of cinnamoyl anthranilates. Bioorg. Med. Chem. Lett. 19, 7003\u20137006. https:\/\/doi.org\/10.1016\/j.bmcl.2009.09.120 (2009).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"4845_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134392","volume":"10","author":"D Deliyanti","year":"2015","unstructured":"Deliyanti, D. et al. FT011, a novel cardiorenal protective drug, reduces inflammation, gliosis and vascular injury in rats with diabetic retinopathy. PLoS\u00a0One 10, e0134392. https:\/\/doi.org\/10.1371\/journal.pone.0134392 (2015).","journal-title":"PLoS\u00a0One"},{"key":"4845_CR33","doi-asserted-by":"publisher","first-page":"e0132643","DOI":"10.1371\/journal.pone.0132643","volume":"10","author":"Y Gong","year":"2015","unstructured":"Gong, Y. et al. Optimization of an image-guided laser-induced choroidal neovascularization model in mice. PLoS\u00a0One 10, e0132643. https:\/\/doi.org\/10.1371\/journal.pone.0132643 (2015).","journal-title":"PLoS\u00a0One"},{"key":"4845_CR34","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/nprot.2013.135","volume":"8","author":"V Lambert","year":"2013","unstructured":"Lambert, V. et al. Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nat. Protoc. 8, 2197\u20132211. https:\/\/doi.org\/10.1038\/nprot.2013.135 (2013).","journal-title":"Nat. Protoc."},{"key":"4845_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030310","volume":"3","author":"RS Apte","year":"2006","unstructured":"Apte, R. S., Richter, J., Herndon, J. & Ferguson, T. A. Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med. 3, e310. https:\/\/doi.org\/10.1371\/journal.pmed.0030310 (2006).","journal-title":"PLoS Med."},{"key":"4845_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000453550","volume":"237","author":"L Li","year":"2017","unstructured":"Li, L., Heiduschka, P., Alex, A. F., Niek\u00e4mper, D. & Eter, N. Behaviour of CD11b-positive cells in an animal model of laser-induced choroidal neovascularisation. Ophthalmologica 237, 29\u201341. https:\/\/doi.org\/10.1159\/000453550 (2017).","journal-title":"Ophthalmologica"},{"key":"4845_CR37","first-page":"414","volume":"11","author":"JH Zhou","year":"2005","unstructured":"Zhou, J. H. et al. Neutrophils promote experimental choroidal neovascularization. Mol. Vis. 11, 414\u2013424 (2005).","journal-title":"Mol. Vis."},{"key":"4845_CR38","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1136\/bjo.2003.036392","volume":"88","author":"C Tsutsumi-Miyahara","year":"2004","unstructured":"Tsutsumi-Miyahara, C. et al. The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation. Br. J. Ophthalmol. 88, 1217\u20131222. https:\/\/doi.org\/10.1136\/bjo.2003.036392 (2004).","journal-title":"Br. J. Ophthalmol."},{"key":"4845_CR39","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.4049\/jimmunol.177.3.1872","volume":"177","author":"NS Bora","year":"2006","unstructured":"Bora, N. S. et al. Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: Role of factor B and factor H. J. Immunol. 177, 1872 (2006).","journal-title":"J. Immunol."},{"key":"4845_CR40","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1073\/pnas.0408835103","volume":"103","author":"M Nozaki","year":"2006","unstructured":"Nozaki, M. et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc. Natl. Acad. Sci. 103, 2328 (2006).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"4845_CR41","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1167\/iovs.08-3044","volume":"50","author":"H Mochimaru","year":"2009","unstructured":"Mochimaru, H. et al. Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization. Investig. Ophthalmol. Vis. Sci. 50, 4410\u20134415. https:\/\/doi.org\/10.1167\/iovs.08-3044 (2009).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"4845_CR42","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1093\/hmg\/ddq129","volume":"19","author":"NV Strunnikova","year":"2010","unstructured":"Strunnikova, N. V. et al. Transcriptome analysis and molecular signature of human retinal pigment epithelium. Hum. Mol. Genet. 19, 2468\u20132486. https:\/\/doi.org\/10.1093\/hmg\/ddq129 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"4845_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141597","volume":"10","author":"A Bennis","year":"2015","unstructured":"Bennis, A. et al. Comparison of mouse and human retinal pigment epithelium gene expression profiles: Potential implications for age-related macular degeneration. PLoS\u00a0One 10, e0141597. https:\/\/doi.org\/10.1371\/journal.pone.0141597 (2015).","journal-title":"PLoS\u00a0One"},{"key":"4845_CR44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","volume":"18","author":"A Fabregat","year":"2017","unstructured":"Fabregat, A. et al. Reactome pathway analysis: A high-performance in-memory approach. BMC Bioinform. 18, 142. https:\/\/doi.org\/10.1186\/s12859-017-1559-2 (2017).","journal-title":"BMC Bioinform."},{"key":"4845_CR45","doi-asserted-by":"publisher","unstructured":"Arvaniti, E. et al. Whole-transcriptome analysis of UUO mouse model of renal fibrosis reveals new molecular players in kidney diseases. Sci. Rep. 6, 26235. https:\/\/doi.org\/10.1038\/srep26235. https:\/\/www.nature.com\/articles\/srep26235#supplementary-information (2016).","DOI":"10.1038\/srep26235"},{"key":"4845_CR46","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4049\/jimmunol.1000964","volume":"187","author":"TJ Liu","year":"2011","unstructured":"Liu, T. J. et al. FIZZ2\/RELM-beta induction and role in pulmonary fibrosis. J. Immunol. 187, 450\u2013461. https:\/\/doi.org\/10.4049\/jimmunol.1000964 (2011).","journal-title":"J. Immunol."},{"key":"4845_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1242\/dmm.004077","volume":"4","author":"TR Cox","year":"2011","unstructured":"Cox, T. R. & Erler, J. T. Remodeling and homeostasis of the extracellular matrix: Implications for fibrotic diseases and cancer. Dis. Model. Mech. 4, 165\u2013178. https:\/\/doi.org\/10.1242\/dmm.004077 (2011).","journal-title":"Dis. Model. Mech."},{"key":"4845_CR48","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.ajpath.2015.11.014","volume":"186","author":"K Ishikawa","year":"2016","unstructured":"Ishikawa, K. et al. alphaBeta-crystallin regulates subretinal fibrosis by modulation of epithelial\u2013mesenchymal transition. Am. J. Pathol. 186, 859\u2013873. https:\/\/doi.org\/10.1016\/j.ajpath.2015.11.014 (2016).","journal-title":"Am. J. Pathol."},{"key":"4845_CR49","first-page":"119","volume":"8","author":"HE Grossniklaus","year":"2002","unstructured":"Grossniklaus, H. E. et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol. Vis. 8, 119\u2013126 (2002).","journal-title":"Mol. Vis."},{"key":"4845_CR50","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1167\/iovs.11-8232","volume":"53","author":"S Fujimura","year":"2012","unstructured":"Fujimura, S. et al. Angiostatic effect of CXCR3 expressed on choroidal neovascularization. Investig. Ophthalmol. Vis. Sci. 53, 1999\u20132006. https:\/\/doi.org\/10.1167\/iovs.11-8232 (2012).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"4845_CR51","first-page":"352","volume":"22","author":"F Liu","year":"2016","unstructured":"Liu, F. et al. Aqueous humor cytokine profiling in patients with wet AMD. Mol. Vis. 22, 352\u2013361 (2016).","journal-title":"Mol. Vis."},{"key":"4845_CR52","doi-asserted-by":"publisher","first-page":"e0203337","DOI":"10.1371\/journal.pone.0203337","volume":"13","author":"J Spindler","year":"2018","unstructured":"Spindler, J., Zandi, S., Pfister, I. B., Gerhardt, C. & Garweg, J. G. Cytokine profiles in the aqueous humor and serum of patients with dry and treated wet age-related macular degeneration. PLoS\u00a0One 13, e0203337. https:\/\/doi.org\/10.1371\/journal.pone.0203337 (2018).","journal-title":"PLoS\u00a0One"},{"key":"4845_CR53","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1167\/iovs.16-19772","volume":"57","author":"S Rezar-Dreindl","year":"2016","unstructured":"Rezar-Dreindl, S. et al. The intraocular cytokine profile and therapeutic response in persistent neovascular age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 57, 4144\u20134150. https:\/\/doi.org\/10.1167\/iovs.16-19772 (2016).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"4845_CR54","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1167\/iovs.09-3910","volume":"51","author":"FM Mo","year":"2010","unstructured":"Mo, F. M., Proia, A. D., Johnson, W. H., Cyr, D. & Lashkari, K. Interferon gamma-inducible protein-10 (IP-10) and eotaxin as biomarkers in age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 51, 4226\u20134236. https:\/\/doi.org\/10.1167\/iovs.09-3910 (2010).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"4845_CR55","first-page":"855","volume":"37","author":"PF Lopez","year":"1996","unstructured":"Lopez, P. F., Sippy, B. D., Lambert, H. M., Thach, A. B. & Hinton, D. R. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Investig. Ophthalmol. Vis. Sci. 37, 855\u2013868 (1996).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"4845_CR56","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/archopht.123.7.914","volume":"123","author":"HE Grossniklaus","year":"2005","unstructured":"Grossniklaus, H. E. et al. Histopathologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: Submacular Surgery Trials Report No. 7. Arch. Ophthalmol. 123, 914\u2013921. https:\/\/doi.org\/10.1001\/archopht.123.7.914 (2005).","journal-title":"Arch. Ophthalmol."},{"key":"4845_CR57","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.12659\/MSM.889887","volume":"20","author":"M Nita","year":"2014","unstructured":"Nita, M., Strza\u0142ka-Mrozik, B., Grzybowski, A., Mazurek, U. & Romaniuk, W. Age-related macular degeneration and changes in the extracellular matrix. Med. Sci. Monit. 20, 1003\u20131016. https:\/\/doi.org\/10.12659\/MSM.889887 (2014).","journal-title":"Med. Sci. Monit."},{"key":"4845_CR58","first-page":"2194","volume":"39","author":"B Steen","year":"1998","unstructured":"Steen, B., Sejersen, S., Berglin, L., Seregard, S. & Kvanta, A. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Investig. Ophthalmol. Vis. Sci. 39, 2194\u20132200 (1998).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"4845_CR59","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00018-010-0476-6","volume":"68","author":"J Lecomte","year":"2011","unstructured":"Lecomte, J. et al. Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization. Cell. Mol. Life Sci. 68, 677\u2013686. https:\/\/doi.org\/10.1007\/s00018-010-0476-6 (2011).","journal-title":"Cell. Mol. Life Sci."},{"key":"4845_CR60","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S0002-9440(10)64401-X","volume":"161","author":"V Lambert","year":"2002","unstructured":"Lambert, V. et al. Matrix metalloproteinase-9 contributes to choroidal neovascularization. Am. J. Pathol. 161, 1247\u20131253. https:\/\/doi.org\/10.1016\/S0002-9440(10)64401-X (2002).","journal-title":"Am. J. Pathol."},{"key":"4845_CR61","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1096\/fj.03-0113fje","volume":"17","author":"V Lambert","year":"2003","unstructured":"Lambert, V. et al. MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J. 17, 2290\u20132292. https:\/\/doi.org\/10.1096\/fj.03-0113fje (2003).","journal-title":"FASEB J."},{"key":"4845_CR62","first-page":"87","volume":"16","author":"E Yamada","year":"2001","unstructured":"Yamada, E. et al. TiMP-1 promotes VEGF-induced neovascularization in the retina. Histol. Histopathol. 16, 87\u201397 (2001).","journal-title":"Histol. Histopathol."},{"key":"4845_CR63","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.exer.2014.11.001","volume":"129","author":"SS Whitmore","year":"2014","unstructured":"Whitmore, S. S. et al. Transcriptomic analysis across nasal, temporal, and macular regions of human neural retina and RPE\/choroid by RNA-Seq. Exp. Eye Res. 129, 93\u2013106. https:\/\/doi.org\/10.1016\/j.exer.2014.11.001 (2014).","journal-title":"Exp. Eye Res."},{"key":"4845_CR64","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0002-9440(10)63975-2","volume":"158","author":"L Nelimarkka","year":"2001","unstructured":"Nelimarkka, L. et al. Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis. Am. J. Pathol. 158, 345\u2013353. https:\/\/doi.org\/10.1016\/S0002-9440(10)63975-2 (2001).","journal-title":"Am. J. Pathol."},{"key":"4845_CR65","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1159\/000081806","volume":"41","author":"E Sch\u00f6nherr","year":"2004","unstructured":"Sch\u00f6nherr, E. et al. Decorin deficiency leads to impaired angiogenesis in injured mouse cornea. J. Vasc. Res. 41, 499\u2013508. https:\/\/doi.org\/10.1159\/000081806 (2004).","journal-title":"J. Vasc. Res."},{"key":"4845_CR66","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41467-018-08125-6","volume":"10","author":"M Zhao","year":"2019","unstructured":"Zhao, M. et al. Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration. Nat. Commun. 10, 369\u2013369. https:\/\/doi.org\/10.1038\/s41467-018-08125-6 (2019).","journal-title":"Nat. Commun."},{"key":"4845_CR67","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3980\/j.issn.2222-3959.2012.03.11","volume":"5","author":"H Zhang","year":"2012","unstructured":"Zhang, H. & Liu, Z.-L. Transforming growth factor-\u03b2 neutralizing antibodies inhibit subretinal fibrosis in a mouse model. Int. J. Ophthalmol. 5, 307\u2013311. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2012.03.11 (2012).","journal-title":"Int. J. Ophthalmol."},{"key":"4845_CR68","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1016\/j.ajpath.2017.06.018","volume":"187","author":"A Schlecht","year":"2017","unstructured":"Schlecht, A. et al. Deletion of endothelial transforming growth factor-\u03b2 signaling leads to choroidal neovascularization. Am. J. Pathol. 187, 2570\u20132589. https:\/\/doi.org\/10.1016\/j.ajpath.2017.06.018 (2017).","journal-title":"Am. J. Pathol."},{"key":"4845_CR69","doi-asserted-by":"publisher","first-page":"7090","DOI":"10.1167\/iovs.11-7300","volume":"52","author":"S Recalde","year":"2011","unstructured":"Recalde, S. et al. Transforming growth factor-\u03b2 inhibition decreases diode laser-induced choroidal neovascularization development in rats: P17 and P144 peptides. Investig. Ophthalmol. Vis. Sci. 52, 7090\u20137097. https:\/\/doi.org\/10.1167\/iovs.11-7300 (2011).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"4845_CR70","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.3390\/ijms19113363","volume":"19","author":"GM Tosi","year":"2018","unstructured":"Tosi, G. M., Orlandini, M. & Galvagni, F. The controversial role of TGF-\u03b2 in neovascular age-related macular degeneration pathogenesis. Int. J. Mol. Sci. 19, 3363. https:\/\/doi.org\/10.3390\/ijms19113363 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"4845_CR71","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1158\/0008-5472.CAN-18-0327","volume":"78","author":"JW Purcell","year":"2018","unstructured":"Purcell, J. W. et al. LRRC15 is a novel mesenchymal protein and stromal target for antibody\u2013drug conjugates. Cancer Res. 78, 4059. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0327 (2018).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-04845-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-04845-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-04845-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T17:20:46Z","timestamp":1669310446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-04845-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4845"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-04845-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]},"assertion":[{"value":"1 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prof. D.K. is employed by OccuRx Pty Ltd, shareholder of Occurx Pty Ltd and has issued patents relating to the composition of OCX063 and its use for eye diseases. Prof. E.F. received funding support by Occurx Pty Ltd to conduct the research reported here. Dr. A.B. institution received payment by Occurx Pty Ltd to conduct research reported here otherwise is funded by NHMRC ID:1141587. Dr FK is a current employee of Occurx Pty Ltd. Dr. RK received payment as a consultant to Occurx Pty Ltd.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"859"}}